Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 25;7(8):e593. doi: 10.1038/bcj.2017.74

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Kaplan–Meier survival analysis according to SOX4 expression in AML patients. Representative immunocytochemical stain of SOX4 protein in bone marrow specimens from patients with low SOX4 protein (a) and with high SOX4 protein (b). Overall survival and disease-free survival were analyzed in all patients with de novo AML (c, d), in patients with non-M3 subtypes (e, f), patients with intermediate-risk cytogenetics (g, h) and patients with normal cytogenetics (i, j). Number of patients and median survival time are indicated in each subgroup.

Kaplan–Meier survival analysis according to SOX4 expression in AML patients. Representative immunocytochemical stain of SOX4 protein in bone marrow specimens from patients with low SOX4 protein (a) and with high SOX4 protein (b). Overall survival and disease-free survival were analyzed in all patients with de novo AML (c, d), in patients with non-M3 subtypes (e, f), patients with intermediate-risk cytogenetics (g, h) and patients with normal cytogenetics (i, j). Number of patients and median survival time are indicated in each subgroup.